News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Genetown
Orthofix International NV Files Definitive Proxy Statement
January 13, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
BOSTON--(BUSINESS WIRE)--Orthofix International N.V. (NASDAQ: OFIX) (the Company) announced today that it has filed a Definitive Proxy Statement with the SEC objecting to a proposal by Ramius LLC to call a special shareholder meeting.
Twitter
LinkedIn
Facebook
Email
Print
MORE ON THIS TOPIC
Job Trends
Massachusetts’ Life Sciences Job Growth Slows, but 10-Year Outlook Remains Strong: Report
June 12, 2024
·
4 min read
·
Angela Gabriel
Genetown
The Best Way to Answer Salary Interview Questions
June 11, 2024
·
4 min read
·
Lorenzo Soliman
Job Trends
Life Sciences R&D, Manufacturing Talent Becoming More Difficult to Find: Report
June 6, 2024
·
3 min read
·
Greg Slabodkin
FDA
Sarepta Seeks Label Expansion, Bigger Market for DMD Gene Therapy
May 7, 2024
·
4 min read
·
Tyler Patchen
